ValuEngine reduces Surgery Partners to 'sell' — 3 quick notes

ValuEngine lowered its rating on Surgery Partners' shares from a "hold" to a "sell," according to The Ledger Gazette.

Here are three quick notes:

1. Surgery Partners' shares opened Nov. 24 trading at $8.60 per share.

2. The company's P/E ratio totals 57.

3. Surgery Partners' debt-to-equity ratio is 1.56.

More articles on transactions/valuations:
Illinois hospital completes $9.4M outpatient surgery center expansion — 3 insights
Doheny Eye Institute purchases new $50M facility — 5 key notes
Surgery Partners loses up to $9M in Q3 revenue from Hurricanes Harvey, Irma & more: 4 ASC company notes

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months